159 related articles for article (PubMed ID: 8693872)
1. The neurobiology of Alzheimer's disease.
Brion JP
Acta Clin Belg; 1996; 51(2):80-90. PubMed ID: 8693872
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
3. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
4. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary tangles and Alzheimer's disease.
Brion JP
Eur Neurol; 1998 Oct; 40(3):130-40. PubMed ID: 9748670
[TBL] [Abstract][Full Text] [Related]
6. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
7. Neurobiology of Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1996; 57 Suppl 14():5-8. PubMed ID: 9024330
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Alzheimer's disease.
Gooch MD; Stennett DJ
Am J Health Syst Pharm; 1996 Jul; 53(13):1545-57; quiz 1603-4. PubMed ID: 8809275
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.
Wischik CM; Harrington CR; Mukaetova-Ladinska EB; Novak M; Edwards PC; McArthur FK
Ciba Found Symp; 1992; 169():268-93; discussion 293-302. PubMed ID: 1490426
[TBL] [Abstract][Full Text] [Related]
11. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
[TBL] [Abstract][Full Text] [Related]
12. The role of neurofibrillary tangles in Alzheimer disease.
Brion JP
Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
[TBL] [Abstract][Full Text] [Related]
13. [Cellular lesions in Alzheimer's disease: structural and molecular analysis].
Brion JP
Bull Mem Acad R Med Belg; 1992; 147(11-12):481-9; discussion 490-1. PubMed ID: 1341572
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease.
Tolnay M; Villoz N; Probst A; Miserez AR
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):80-4. PubMed ID: 12581343
[No Abstract] [Full Text] [Related]
15. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.
Beffert U; Poirier J
Ann N Y Acad Sci; 1996 Jan; 777():166-74. PubMed ID: 8624080
[TBL] [Abstract][Full Text] [Related]
18. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
19. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
20. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]